Overview
BPC-157, also known as Body Protection Compound 157, is a synthetic peptide derived from a protein in the human digestive system. Comprised of 15 amino acids, BPC-157 has shown promise in studies as a potential therapy for healing joints, tendons, muscles, nerve tissue, and supporting gastrointestinal health. By leveraging the body’s natural healing pathways, BPC-157 offers a targeted approach to tissue repair and inflammation reduction without the side effects associated with many synthetic medications.
BPC-157, also known as Body Protection Compound 157, is a synthetic peptide derived from a protein in the human digestive system. Comprised of 15 amino acids, BPC-157 has shown promise in studies as a potential therapy for healing joints, tendons, muscles, nerve tissue, and supporting gastrointestinal health. By leveraging the body’s natural healing pathways, BPC-157 offers a targeted approach to tissue repair and inflammation reduction without the side effects associated with many synthetic medications.
Key Benefits of BPC-157
- Accelerates Wound Healing: Promotes faster healing of tendons, muscles, ligaments, and skin.
- Supports Digestive Health: Helps address leaky gut, IBS, and Crohn’s disease in studies.
- Reduces Inflammation: Assists with systemic inflammation, including arthritis-related symptoms.
- Stimulates Blood Vessel Formation: Encourages angiogenesis, crucial for repair and recovery.
- Enhances Nitric Oxide Production: Improves circulation and cellular repair.
- Potential Pain Relief: Exhibits analgesic effects that may help with injury-related discomfort.
How It Works
BPC-157 is reported to interact with growth-related pathways, stimulating collagen production and new blood vessel formation (angiogenesis). It influences cell-migration and regeneration pathways, including FAK and paxillin signaling, which supports tissue repair across muscles, tendons, ligaments, and the gastrointestinal tract.
BPC-157 is reported to interact with growth-related pathways, stimulating collagen production and new blood vessel formation (angiogenesis). It influences cell-migration and regeneration pathways, including FAK and paxillin signaling, which supports tissue repair across muscles, tendons, ligaments, and the gastrointestinal tract.
Clinical Applications
- Wound and Tissue Healing: Accelerates healing across multiple tissue types.
- Gut Health: Studied for mitigating IBS, ulcerative colitis, and Crohn’s disease.
- Joint Health and Pain Management: Supports tendon, ligament, bone healing, and arthritis care.
- Antioxidant Protection: Reduces oxidative stress and protects against cell damage.
- Enhanced Recovery: Aids faster return to function after injuries.
Research and Evidence
- Wound Healing: Animal studies show increased fibroblast activity, collagen formation, and vascularization, improving healing rates in skin, GI, and muscle injuries.
- Digestive Health: Demonstrated protection of the GI mucosal barrier, improved healing in gastric ulcer models, and defense against GI toxins.
- Muscle, Tendon, and Ligament Repair: In vitro and in vivo studies show improved tendon outgrowth, angiogenesis, and fibroblast migration, even under oxidative stress.
- Neuroprotection: Early evidence of interaction with dopamine pathways and potential to reduce dopamine-related excitability.
Side Effects and Safety
BPC-157 has shown an excellent safety profile in animal studies, with few reported side effects. It does not appear to impact insulin sensitivity or blood glucose levels. While comprehensive human trials are ongoing, current data suggests it is generally well-tolerated.
BPC-157 has shown an excellent safety profile in animal studies, with few reported side effects. It does not appear to impact insulin sensitivity or blood glucose levels. While comprehensive human trials are ongoing, current data suggests it is generally well-tolerated.
Product Information
- Product Name: BPC-157 (300 μg injection, 500 μg capsule)
- Supplied As: Injectable, oral capsule, or nasal spray
- Suggested Usage: For individuals seeking improved recovery from injuries, digestive health support, or relief from chronic inflammation.
Applications
- Wound Healing
- Digestive Health
- Joint Repair
- Inflammation Reduction
Selected Research Summaries
- Wound Models in Rats: Increased collagen, reticulin, and blood vessel development vs. control, suggesting faster healing via granulation and angiogenesis.
- Tendon Healing (Ex-vivo): Promoted tendon outgrowth, cell survival under H₂O₂ stress, and fibroblast migration; associated with F-actin formation and FAK/paxillin activation.
- GI Healing vs. Growth Factors: Showed consistent healing across acute and chronic GI wounds, independent of administration route.
- Broader Pharmacology: Suggested protective “defense system” effects across multiple organs; modulates NO and other pathways.
- Muscle Healing with Steroids: Reversed corticosteroid-worsened muscle damage and restored function in rat models.
- Dopamine-Linked Studies: Reduced amphetamine-induced excitability and countered haloperidol effects in animal models.
- Early Human Data: Initial enema studies in healthy volunteers indicated good tolerability; further trials planned.
Molecular Details
- Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- Molecular Formula: C62H98N15O22
- Molecular Weight: 1419.556 g/mol
- PubChem CID: 108101
References (Selected)
- Huang T., et al. Drug Des. Devel. Ther. 2015.
- Drmic D., et al. World J. Gastroenterol. 2018.
- Amic F., et al. World J. Gastroenterol. 2018.
- Duzel A., et al. World J. Gastroenterol. 2017.
- Vukojević J., et al. Vascul. Pharmacol. 2018.
- Drmic D., et al. World J. Gastroenterol. 2017.
- Hsieh M-J., et al. J. Mol. Med. 2017.
- Grabarevic Z., et al. J. Physiol. Paris 1997.
- Sikiric P., et al. Curr. Pharm. Des. 2018.
- Seiwerth S., et al. Curr. Pharm. Des. 2018.
- Chang C-H., et al. J. Appl. Physiol. 2010.
- Hu Y-L., et al. Sci. Rep. 2014.
- Škrlec K., et al. Appl. Microbiol. Biotechnol. 2018.
- Strinic D., et al. Life Sci. 2017.
- Jelovac N., et al. Eur. J. Pharmacol. 1999.
- Tlak Gajger I., et al. J. Vet. Pharmacol. Ther. 2018.